Skip to main content
OpenTrials

Clinical trial condition

Metastatic Lung Cancer

Explore clinical trials studying Metastatic Lung Cancer. Study availability and eligibility vary by location and protocol.

37 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Lung Cancer trial results

Completed

A Study of ASN007 in Patients With Advanced Solid Tumors

NCT03415126

Conditions
Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +51 more
Locations
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
View Trial Details
Completed

Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously

NCT01543672

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +6 more
Locations
  • Beaumont Hospital, Royal Oak Royal Oak, Michigan, United States
  • Thomas Jefferson University/ Kimmel Cancer Center Philadelphia, Pennsylvania, United States
  • Prinses Margaret Hospital Toronto, Ontario, Canada
  • Universitätsklinikum Würzburg Würzburg, Bavaria, Germany
View Trial Details
Active, Not Recruiting

Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

NCT05256290

Conditions
Advanced Lung Carcinoma, Advanced Non-Small Cell Squamous Lung Cancer, Brain Diseases, +23 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Huntington Beach Huntington Beach, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
View all 25 locations
View Trial Details
Active, Not Recruiting

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

NCT05609578

Conditions
Advanced NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Local Institution - 017-936C Fountain Valley, California, United States
  • Local Institution - 017-936 Fountain Valley, California, United States
  • Local Institution - 017-851 Fullerton, California, United States
  • Local Institution - 017-540 San Francisco, California, United States
View all 94 locations
View Trial Details
Active, Not Recruiting

Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer

NCT04940325

Conditions
Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations
  • Institut Bergonié Bordeaux, France
  • Institut de Cancérologie, CHRU Morvan de Brest Brest, France
  • Centre François Baclesse Caen, France
  • Centre Hospitalier Intercommunal de Créteil Créteil, France
View Trial Details

Related conditions